A newly presented study has uncovered troubling molecular changes in the cervix associated with a common parasitic infection, ...

Biocon’s share price rose 5.5% after USFDA approved JOBEVNE, a biosimilar cancer drug. This marks the company’s seventh USFDA ...

A roundup of 2025's most impactful nanomaterial innovations. From energy storage and flexible electronics to cancer treatment ...

Jobevne is a vascular endothelial growth factor (VEGF) impediment that sticks with VEGF and restrain the interaction with its ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Amezalpat (TPST-1120) is Phase 3-ready: completed FDA and EMA interactions for first-line pivotal study in hepatocellular carcinoma (HCC); global ...

Increased dietary folic acid intake may lead to adverse health effects, including inflammation and neurotoxicity, ...

Hydrogels, which are soft materials formed by cross-linking polymers, could have a variety of medical applications. In ...

Download this technical note to explore how a qualitative, real-time, high-throughput in vitro tube formation assay helps ...

A research team led by the Guangzhou Institutes of Biomedicine and Health of the Chinese Academy of Sciences has constructed ...

Tharimmune (THAR) announced preclinical data from its expanded pipeline with HS1940, a dual-target multispecific biologic engineered to bind to ...

The ranibizumab biosimilar Ongavia exhibited significantly less improvement in visual acuity and retinal thickness compared ...